In the original publication [1], there were overlaps in Figure 10 as published. The corrected Figure 10 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 10.
Histopathological analysis (at day 21) of the induced-breast-tumor tissue and major surrounding organs of breast-tumor-bearing BALB/c mice after treatment with PBS (1×, pH 7.4; 20 mL/kg/day), free DOX (5 mg/kg/day), or TiO2 NPs (5 mg/kg/day).
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Iqbal H., Razzaq A., Uzair B., Ain N.U., Sajjad S., Althobaiti N.A., Albalawi A.E., Menaa B., Haroon M., Khan M., et al. Breast Cancer Inhibition by Biosynthesized Titanium Dioxide Nanoparticles Is Comparable to Free Doxorubicin but Appeared Safer in BALB/c Mice. Materials. 2021;14:3155. doi: 10.3390/ma14123155. [DOI] [PMC free article] [PubMed] [Google Scholar]